27 January 2012 in Lab on a Chip
A large part of the excitement behind microfluidics is in its potential for producing practical devices, but surprisingly few lab-on-a-chip based technologies have been successfully introduced into the market. Here, we review current work in commercializing microfluidic technologies, with a focus on point-of-care diagnostics applications. We will also identify challenges to commercialization, including lessons drawn from our experience in Claros Diagnostics. Moving forward, we discuss the need to strike a balance between achieving real-world impact with integrated devices versus design of novel single microfluidic components.
27 October 2006 in Lab on a Chip
A rapidly emerging field in lab-on-a-chip (LOC) research is the development of devices to improve the health of people in developing countries. In this review, we identify diseases that are most in need of new health technologies, discuss special design criteria for LOC devices to be deployed in a variety of resource-poor settings, and review past research into LOC devices for global health. We focus mainly on diagnostics, the nearest-term application in this field.
13 December 2016 in Analytical Chemistry
TLTassaneewan Laksanasopin
4 February 2015 in Science Translational Medicine
TLTassaneewan Laksanasopin
+15
A smartphone accessory can perform a point-of-care test that simultaneously detects three infectious disease markers from fingerprick whole blood in 15 min, as operated by health care workers trained on a software app.
18 January 2017 in Science Robotics
Implantable microdevices often have static components rather than moving parts and exhibit limited biocompatibility. This paper demonstrates a fast manufacturing method that can produce features in biocompatible materials down to tens of micrometers in scale, with intricate and composite patterns in each layer. By exploiting the unique mechanical properties of hydrogels, we developed a “locking mechanism” for precise actuation and movement of freely moving parts, which can provide functions such as valves, manifolds, rotors, pumps, and delivery of payloads. Hydrogel components could be tuned within a wide range of mechanical and diffusive properties and can be controlled after implantation without a sustained power supply. In a mouse model of osteosarcoma, triggering of release of doxorubicin from the device over 10 days showed high treatment efficacy and low toxicity, at 1/10 of the standard systemic chemotherapy dose. Overall, this platform, called implantable microelectromechanical systems (iMEMS), enables development of biocompatible implantable microdevices with a wide range of intricate moving components that can be wirelessly controlled on demand, in a manner that solves issues of device powering and biocompatibility.
4 February 2010 in Advanced Materials